find a clinical trial
If you have any questions or are interested in participating in one of our Clinical Trials, please take note of the associated protocol number and contact our team at 201-518-3587, or email us.
351
Clinical Trials
Advanced Solid Tumors
Phase I
Enrolling
nct/study# NCT05684965 / XTX301
A First-in-Human, Multicenter, Phase 1, Open-Label Study of XTX301 in Patients With Advanced Solid Tumors
Learn More
SCLC
Phase I
Enrolling
nct/study# NCT06179069 / ZL-1310-001
An Open-label, Multicenter Study of ZL-1310 to Evaluate the Safety, Tolerability, and Pharmacokinetics in Subjects with Small Cell Lung Cancer
Learn More
Hepatocellular Carcinoma
Phase I
Enrolling
nct/study# NCT07164313 / ZWI-ZW251-101
A First-In-Human, Phase 1, Open-Label, Multicenter Study of ZW251, a Novel Glypican-3 Targeting Antibody-Drug Conjugate, in Participants with Advanced Solid Tumors, Including Hepatocellular Carcinoma
Learn More
Radiation Oncology
Unspecified
Enrolling
nct/study# N/A / MRI-STUDY-2015-1320
Identification of Novel Metabolomics and MRI Based Biomarkers Predictive of Early Radiation Induced Cardiac Toxicity Following Treatment for Thoracic Malignancies
Learn More
Thoracic (Lung)
Phase II
Enrolling
nct/study# NCT05498428 / 61186372NSC2002-PALOMA-2
A Phase 2, Open-Label, Parallel Cohort Study of Subcutaneous Amivantamab in Multiple Regimens in Patients with Advanced or Metastatic Solid Tumors including EGFR-mutated Non-Small Cell Lung Cancer
Learn More
Thoracic (Lung)
Phase II
Enrolling
nct/study# NCT06248515 / CO-US-979-6770
A Phase II Parallel Arm Study of Sacituzumab Govitecan-hziy in Patients with Advanced Thymoma and Thymic Carcinoma
Learn Morewe are here for you
For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.